Overview

Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)

Status:
RECRUITING
Trial end date:
2035-03-01
Target enrollment:
Participant gender:
Summary
An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Fenofibrate in Subjects with Primary Biliary Cholangitis (PBC)
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Xijing Hospital of Digestive Diseases
Treatments:
Fenofibrate